Table 5.
Direct costs (€2014) by GOLD state and type of event
| Event/GOLD | CAN43,44 | ESP45,46 | SWE47,48 | UK26 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| II | III | IV | II | III | IV | II | III | IV | II | III | IV | |
| No Ex | 95 | 284 | 416 | 366 | 1,060 | 1,751 | 141 | 333 | 472 | 150 | 321 | 531 |
| Non-SevEx | 391 | 580 | 712 | 669 | 1,363 | 2,054 | 486 | 678 | 817 | 153 | 474 | 684 |
| SevEex | 7,108 | 7,297 | 7,428 | 1,822 | 2,516 | 3,207 | 3,058 | 3,250 | 3,389 | 4,832 | 5,153 | 5,363 |
Notes: Ex-rates 2014: CAN (C$ to €: 0.68)40; SWE (SEK to €: 0.11)41; UK (£ to €: 1.24).42 Where necessary, costs have been inflated to 2014 year prices and recalculated to reflect 3-month cycle.
Abbreviations: GOLD, Global Initiative for Chronic Obstructive Lung Disease; GOLD II, GOLD classification indicating moderate COPD; COPD, chronic obstructive pulmonary disease; GOLD III, GOLD classification indicating severe COPD; GOLD IV, GOLD classification indicating very severe COPD; CAN, Canada; ESP, Spain, SWE, Sweden; No Ex, no exacerbation; Non-SevEx, nonsevere exacerbation; SevEx, severe exacerbation; SEK, Swedish krona.